Eyes on Chi­na stocks: Lon­car loads new ETF with his picks for most promis­ing biotechs on HKEX and Nas­daq

An in­vestor group based in the Mid­west is tap­ping the boom­ing biotech scene in Chi­na to launch a new in­vest­ment ve­hi­cle for traders in­ter­est­ed in promis­ing Chi­nese ven­tures.

Lon­car In­vest­ments, found­ed by in­de­pen­dent biotech in­vestor Brad Lon­car, se­lect­ed 28 com­pa­nies — some list­ed on the Hong Kong Stock Ex­change and the rest on the Nas­daq — to wrap up in­to an ex­change-trad­ed fund: Lon­car Chi­na Bio­Phar­ma ETF. The tick­er is Nas­daq: $CHNA.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.